KEY FEATURES BPC-157 lyophilised research-grade peptide 5mg per vial Independent HPLC-MS verified to 99.67% purity (CoA on public Lab Results portal) Single-batch fill, single-batch chromatogram no blending across lots Synthesised in accredited contract laboratories with full QA paper trail Crimp-sealed, tamper-evident research vial in unbranded outer packaging Dispatched from Australia on Auspost Express with insulated cold-pack option SPECIFICATIONS Product Name BPC-157 Category Healing Research Peptides Grade Research grade laboratory use only Quantity 5mg per vial Form Lyophilised powder cake Purity 99.67% verified by HPLC-MS Appearance White to off-white lyophilised solid Storage 28 C lyophilised
Direct Antioxidant: NAC also acts as a direct antioxidant, scavenging free radicals and neutralizing reactive oxygen species (ROS)
Some individuals may observe changes within a few weeks, while others might require longer treatment periods
10.1002/nbm.3045 86
In the realm of cell-based therapies and antibodydrug conjugates (ADCs), CT041, a CLDN18.2-targeted CAR-T product, is being studied in gastrointestinal cancers (NCT04404595), while enfortumab vedotin, targeting Nectin-4, is under investigation for metastatic castration-resistant prostate cancer (NCT04754191)